Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

No longer available × tucatinib × 1 year × Clear all

Status

Recruiting 16 Active not recruiting 8 Terminated 3 Completed 3 Not yet recruiting 2 Suspended 1 Approved for marketing 1

Sponsor

Interventions

Suspensions 2 Powders 2 zanidatamab 1 trametinib 1 taletrectinib 1 ruxolitinib 1 revumenib 1 patritumab deruxtecan 1 omburtamab I-131 1 omaveloxolone 1 leronlimab 1 derazantinib 1 dabrafenib 1 capmatinib 1 asparaginase erwinia chrysanthemi recombinant 1 apalutamide 1 Standard of Care 1 Paclitaxel 1 Nivolumab 1 HMPL-013 1 Everolimus 1 Docetaxel 1 Asparaginase 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡